The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss
Background. The modified Bushen Antai recipe (BSAT) is a centuries-old traditional Chinese medicine that we use in our center as a therapy against pregnancy loss. Our study aimed to explore the potential benefit and mechanism of BSAT in pregnant rats with mifepristone-induced pregnancy loss. Materia...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/8312020 |
id |
doaj-883d8f9187f14a44a5b796a7d43687d4 |
---|---|
record_format |
Article |
spelling |
doaj-883d8f9187f14a44a5b796a7d43687d42020-11-24T22:10:39ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882019-01-01201910.1155/2019/83120208312020The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy LossLi Sun0Zhengwei Yuan1Lingyan Jian2Qinghua Jiang3Siwen Zhang4Jichun Tan5Reproductive Medicine Center, Obstetrics and Gynecology Department, Shengjing Hospital Affiliated to China Medical University, Shenyang 110022, ChinaKey Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital Affiliated to China Medical University, Shenyang 110022, ChinaDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110022, ChinaDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110022, ChinaReproductive Medicine Center, Obstetrics and Gynecology Department, Shengjing Hospital Affiliated to China Medical University, Shenyang 110022, ChinaReproductive Medicine Center, Obstetrics and Gynecology Department, Shengjing Hospital Affiliated to China Medical University, Shenyang 110022, ChinaBackground. The modified Bushen Antai recipe (BSAT) is a centuries-old traditional Chinese medicine that we use in our center as a therapy against pregnancy loss. Our study aimed to explore the potential benefit and mechanism of BSAT in pregnant rats with mifepristone-induced pregnancy loss. Materials and Methods. The signature compounds of the eight BSAT ingredients were analyzed by high-performance liquid chromatography (HPLC). The BSAT group (n = 8) was treated daily with 6.3 ml/kg BSAT from gestation day (D) 0.5 to 10.5 and once with 1.25 mg/kg mifepristone on D 10.5. Normal saline replaced BSAT in the model group (n = 8), and both BSAT and mifepristone in the control group (n = 8). Morphological and histological analyses were performed on D 13.5. Results. BSAT contains eight medicinal ingredients including Cuscuta chinensis and Dipsacus asperoides. The HPLC analysis detected the signature compounds of seven medicinal ingredients in the extract. Embryo resorption rate in the BSAT group was significantly lower than that in the model group, although the number of surviving embryos was similar between the two groups. Hematoxylin and eosin (HE) staining suggested that the maximum cross-sectional area of the placenta and the area ratio of the placental labyrinth in the BSAT group were higher than those in the model group. Immunohistochemical (IHC) staining indicated that the expression of ki67, estrogen receptor alpha (ERα), and progesterone receptor (PR) in the placental labyrinth of the BSAT group was higher than that of the model group. Furthermore, the protein levels of ERα, PR, phospho-Akt/Akt, and phospho-Erk1/2/Erk1/2 in the BSAT group were higher than those in the control group. The mRNA levels of ERα and PR in the BSAT group were higher than those in the control group. Conclusions. BSAT may induce estrogen and progesterone receptors by phosphorylation via the classic Akt and Erk1/2 signaling pathways in the maternal-fetal interface of pregnant rats, thereby reducing the pregnancy loss rate and improving the live birth rate.http://dx.doi.org/10.1155/2019/8312020 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Li Sun Zhengwei Yuan Lingyan Jian Qinghua Jiang Siwen Zhang Jichun Tan |
spellingShingle |
Li Sun Zhengwei Yuan Lingyan Jian Qinghua Jiang Siwen Zhang Jichun Tan The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss Evidence-Based Complementary and Alternative Medicine |
author_facet |
Li Sun Zhengwei Yuan Lingyan Jian Qinghua Jiang Siwen Zhang Jichun Tan |
author_sort |
Li Sun |
title |
The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss |
title_short |
The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss |
title_full |
The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss |
title_fullStr |
The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss |
title_full_unstemmed |
The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss |
title_sort |
modified bushen antai recipe upregulates estrogen and progesterone receptors at the maternal-fetal interface in pregnant rats with mifepristone-induced pregnancy loss |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2019-01-01 |
description |
Background. The modified Bushen Antai recipe (BSAT) is a centuries-old traditional Chinese medicine that we use in our center as a therapy against pregnancy loss. Our study aimed to explore the potential benefit and mechanism of BSAT in pregnant rats with mifepristone-induced pregnancy loss. Materials and Methods. The signature compounds of the eight BSAT ingredients were analyzed by high-performance liquid chromatography (HPLC). The BSAT group (n = 8) was treated daily with 6.3 ml/kg BSAT from gestation day (D) 0.5 to 10.5 and once with 1.25 mg/kg mifepristone on D 10.5. Normal saline replaced BSAT in the model group (n = 8), and both BSAT and mifepristone in the control group (n = 8). Morphological and histological analyses were performed on D 13.5. Results. BSAT contains eight medicinal ingredients including Cuscuta chinensis and Dipsacus asperoides. The HPLC analysis detected the signature compounds of seven medicinal ingredients in the extract. Embryo resorption rate in the BSAT group was significantly lower than that in the model group, although the number of surviving embryos was similar between the two groups. Hematoxylin and eosin (HE) staining suggested that the maximum cross-sectional area of the placenta and the area ratio of the placental labyrinth in the BSAT group were higher than those in the model group. Immunohistochemical (IHC) staining indicated that the expression of ki67, estrogen receptor alpha (ERα), and progesterone receptor (PR) in the placental labyrinth of the BSAT group was higher than that of the model group. Furthermore, the protein levels of ERα, PR, phospho-Akt/Akt, and phospho-Erk1/2/Erk1/2 in the BSAT group were higher than those in the control group. The mRNA levels of ERα and PR in the BSAT group were higher than those in the control group. Conclusions. BSAT may induce estrogen and progesterone receptors by phosphorylation via the classic Akt and Erk1/2 signaling pathways in the maternal-fetal interface of pregnant rats, thereby reducing the pregnancy loss rate and improving the live birth rate. |
url |
http://dx.doi.org/10.1155/2019/8312020 |
work_keys_str_mv |
AT lisun themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT zhengweiyuan themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT lingyanjian themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT qinghuajiang themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT siwenzhang themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT jichuntan themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT lisun modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT zhengweiyuan modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT lingyanjian modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT qinghuajiang modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT siwenzhang modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss AT jichuntan modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss |
_version_ |
1725807239776698368 |